| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13239* | 2021 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1783 | 2017 |
| Dopamine depletion impairs precursor cell proliferation in Parkinson disease GU Höglinger, P Rizk, MP Muriel, C Duyckaerts, WH Oertel, I Caille, ... Nature neuroscience 7 (7), 726-735, 2004 | 1174 | 2004 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 628 | 2011 |
| Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats GU Höglinger, J Féger, A Prigent, PP Michel, K Parain, P Champy, ... Journal of neurochemistry 84 (3), 491-502, 2003 | 419 | 2003 |
| Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation K Ridder, S Keller, M Dams, AK Rupp, J Schlaudraff, D Del Turco, ... PLoS biology 12 (6), e1001874, 2014 | 388 | 2014 |
| Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors B Nait-Oumesmar, N Picard-Riera, C Kerninon, L Decker, D Seilhean, ... Proceedings of the National Academy of Sciences 104 (11), 4694-4699, 2007 | 379 | 2007 |
| The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases G Respondek, M Stamelou, C Kurz, LW Ferguson, A Rajput, WZ Chiu, ... Movement Disorders 29 (14), 1758-1766, 2014 | 372 | 2014 |
| Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches AL Boxer, JT Yu, LI Golbe, I Litvan, AE Lang, GU Höglinger The Lancet Neurology 16 (7), 552-563, 2017 | 368 | 2017 |
| Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease GU Höglinger, G Carrard, PP Michel, F Medja, A Lombès, M Ruberg, ... Journal of neurochemistry 86 (5), 1297-1307, 2003 | 335 | 2003 |
| The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease GU Höglinger, JJ Breunig, C Depboylu, C Rouaux, PP Michel, ... Proceedings of the National Academy of Sciences 104 (9), 3585-3590, 2007 | 324 | 2007 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 315 | 2014 |
| The movement disorder society criteria for the diagnosis of multiple system atrophy GK Wenning, I Stankovic, L Vignatelli, A Fanciulli, G Calandra‐Buonaura, ... Movement Disorders 37 (6), 1131-1148, 2022 | 310 | 2022 |
| Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ... The Lancet Neurology 13 (7), 676-685, 2014 | 298 | 2014 |
| Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe P Champy, GU Höglinger, J Féger, C Gleye, R Hocquemiller, A Laurens, ... Journal of neurochemistry 88 (1), 63-69, 2004 | 279 | 2004 |
| Distribution patterns of tau pathology in progressive supranuclear palsy GG Kovacs, MJ Lukic, DJ Irwin, T Arzberger, G Respondek, EB Lee, ... Acta neuropathologica 140, 99-119, 2020 | 278 | 2020 |
| The differential diagnosis and treatment of atypical parkinsonism J Levin, A Kurz, T Arzberger, A Giese, GU Höglinger Deutsches Ärzteblatt International 113 (5), 61, 2016 | 273 | 2016 |
| Dopamine and adult neurogenesis A Borta, GU Höglinger Journal of neurochemistry 100 (3), 587-595, 2007 | 255 | 2007 |
| Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism F Ros-Bernal, S Hunot, MT Herrero, S Parnadeau, JC Corvol, L Lu, ... Proceedings of the National Academy of Sciences 108 (16), 6632-6637, 2011 | 252 | 2011 |
| The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy GU Höglinger, A Lannuzel, ME Khondiker, PP Michel, C Duyckaerts, ... Journal of neurochemistry 95 (4), 930-939, 2005 | 231 | 2005 |
